Latest Information Update: 30 Mar 2010
At a glance
- Originator Otsuka Pharmaceutical
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 01 Jul 1998 Investigation in Cancer in Japan (Parenteral)
- 07 Jul 1995 Investigation in Cancer in Japan (Parenteral)